Antifungal activity of amphotericin B and itraconazole against filamentous fungi: Comparison of the sensititre yeast one® and NCCLS M38-A reference methods

Journal of Chemotherapy

Volumn 16, Issue 5, 2004, Pages 468-473

  Carrillo Munoz A J ^a   Quindos G ^b   Del Valle, O ^c   Hernandez Molina J M ^d   Santos, P ^e  

^a Associacio Catalana d'Intelligencia Artificial   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL LA INMACULADA   (Spain)

^e Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

Author keywords

Amphotericin B; Filamentous fungi; Itraconazole; Sensititre; Susceptibility

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; COLORIMETRY; CONTROLLED STUDY; DILUTION; FUNGUS; FUNGUS ISOLATION; FUSARIUM; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCEDOSPORIUM;

EID: 8544283039     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.5.468     Document Type: Article

References (28)

1. LaRocco MT, Burgert SJ. Fungal infections in the transplant recipient and laboratory methods for diagnosis. Rev Iberoam Micol 1997; 14: 143-146.
2. Beck-Sague C, Jarvis WR, the National Nosocomial Infection Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247-1251.
3. Rüchel R. Mycotic infections in the immunocompromised patient. Rev Iberoam Micol 1996; 13(Supl. 1): S20-S24.
4. Trick WE, Jarvis WR. Epidemiology of nosocomial fungal infections in the 1990s. Rev Iberoam Micol 1998; 15: 2-6.
5. Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN. Antifungal susceptibility testing. Clin Microbiol Rev 1993; 6: 367-381.
6. Rubio-Calvo MC, Gil-Tomás J, Benito-Ruesca R. Las pruebas in vitro en la evaluación de los agentes antifúngicos. Rev Esp Quimoter 1993; 6: 21.
7. Pemán-García J, Cantón-Lacasa E. Las pruebas de sensibilidad antifúngica en un laboratorio de microbiología clínica. Rev Esp Quimioter 1996; 9: 17-20.
8. Odds FC. Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? Drug Resistance Updates 1998; 1: 11-15.
9. Espinel-Ingroff A. Clinical utility of in vitro antifungal susceptibility testing. Rev Iberoam Micol 2000; 13: 161-166.
10. Odds FC. Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes? Rev Iberoam Micol 1997; 14: 83-84.
11. Espinel-Ingroff A, Warnock DW, Vazquez JA, Arthimgton-Skaggs BA. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance. Med Mycol 2000; 38: 293-304.
12. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-2A. National Committee for Clinical Laboratory Standards, Villanova, Pa, 2002.
13. Espinel-Ingroff A, Bartlett M, Bowden R, Chin NX, Cooper C, Fothergill A, et al. Multicenter evaluation of proposed standardization procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997; 35: 139-43.
14. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-A. 1998.
15. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950-2956.
16. Espinel-ingroff A. Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole and voriconazole. Antimicrob Agents Chemother 2001; 45: 605-607.
17. Manavathu EK, Cutright JL, Loebenberh D, Chandrasekar PH. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH56592). J Antimicrob Chemother 2000; 46: 229-234.
18. Odds FC, Van Gerven F, Espinel-Ingroff A, Bartlett MS, Ghannoum MA, Lancaster MV, et al. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 1998; 42: 282-288.
19. Guarro J, Pujol I, Mayayo E. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother 1999; 43: 1256-1257.
20. Carrillo-Muñoz AJ, Quindós G, Ruesga M, del Valle O, Pemán J, Cantón E, et al. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre™ Yeast One. Mycoses 2004; 47 (accepted for publication).
21. Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 2001; 39: 1360-1367.
22. Meletiadis J, Mouton JW, Meis JF, Bouman BA, Verweij PE. Comparison of the E-test and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species. J. Clin Microbiol 2002; 40: 2876-2885.
23. Martín-Mazuelos E, Peman J, Valverde A, Chaves M, Serrano MC, Canton E. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother 2003; 52: 365-370.
24. Carrillo-Muñoz AJ, Pemán J, Gobernado M. Nuevos antifúngicos. Rev Esp Quimioter 1999; 12: 181-204.
25. Carrillo-Muñoz AJ, Brió S, Quindós G. Una nueva generación de fármacos antifúngicos. Rev Iberoam Micol 2001; 18: 4-7.
26. Pfaller MA, Vu Q, Lancaster M, Espinel-Ingroff A, Fothergill A, Grant C, et al. Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeasts isolates. J Clin Microbiol 1994; 32: 1625-1628.
27. To WK, Fothergill AW, Rinaldi MG. Comparative evaluation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1995; 33: 2660-2664.
28. Jahn B, Stüben A, Bhakdi S. Colorimetric testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5- diphenyl-2H-tetrazolium bromide and alamar blue tests. J Clin Microbiol 1996; 34: 2039-2041.